Showing results (1221-1230 of 1,538) with videos related to
Sort By:
Pageof 154
Genome Research|June 2, 2026
Transfer learning enhances clinical utility of polygenic scores with small, phenotypically refined cohortsYuChung Lin, Christoph Patrick Beier, Zuzana Sobiskova, et al.Journal for Immunotherapy of Cancer|May 5, 2026
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinomaAmeish Govindarajan, Nathaniel Hansen, Benjamin D Mercier, et al.Journal of Medical Genetics|May 24, 2018
Identification of new risk factors for rolandic epilepsy: CNV at Xp22.31 and alterations at cholinergic synapsesLaura Addis, William Sproviero, Sanjeev V Thomas, et al.European Urology|June 9, 2017
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic ProfilingSumanta K Pal, Siraj M Ali, Evgeny Yakirevich, et al.JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.Cancers|October 16, 2025
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder CancerSalvador Jaime-Casas, Wesley Yip, Daniel J Lama, et al.European Urology|August 26, 2019
First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database ConsortiumShaan Dudani, Jeffrey Graham, J Connor Wells, et al.The Oncologist|March 27, 2023
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort AnalysisLuis Meza, Zeynep Zengin, Sabrina Salgia, et al.ESMO Open|June 20, 2024
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumK Takemura, T Yuasa, A Lemelin, et al.Journal for Immunotherapy of Cancer|December 21, 2019
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)Brian I Rini, Dena Battle, Robert A Figlin, et al.Pageof 154